Legacy Financial Advisors’s Bio-Techne TECH Stock Holding History

Legacy Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-172	Closed	-$9K	–	813
2019 Q1	$9K	Buy	+172	New	+$7.74K	﹤0.01%	646

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Legacy Financial Advisors's TECH Position: Q2 2019 in Review

Legacy Financial Advisors sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 172 shares — an estimated $9K sold.

Legacy Financial Advisors first reported a position in TECH in Q1 2019 and held it in 1 quarter. The position peaked at $9K in Q1 2019. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.

Legacy Financial Advisors reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
Legacy Financial Advisors sold 172 Bio-Techne shares in Q2 2019, an estimated $9K.
Legacy Financial Advisors first reported a position in Bio-Techne in Q1 2019 and held it in 1 quarter.
Legacy Financial Advisors's Bio-Techne position peaked at $9K in Q1 2019.
369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.

Based on Legacy Financial Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.